Skip to main content
HCPCS Level II/J-Codes/J3055

J3055 HCPCS Level II Code: Injection, talquetamab-tgvs, 0.25 mg

Medicare Coverage & Payment

  • Medicare coverage: Carrier judgment (CMS coverage code C)
  • Payment category: Drugs (pricing indicator 51)
  • BETOS: O1E — Other drugs
  • Last CMS action effective: April 1, 2024

Source: CMS HCPCS Level II release. Coverage codes indicate how Medicare treats the code, not whether a specific claim will be paid; payer policy and documentation still govern.

Official Registry Overview & Definition

Injection, talquetamab-tgvs, 0.25 mg is a HCPCS Level II code (J3055). CMS assigns coverage code C — Carrier judgment. Short description: Inj talquetamab-tgvs 0.25 mg.

Nearest Codes in This Family

Official HCPCS Level II classifications closest to J3055 in its code family, with their registry titles.

  • J3000 — Injection, streptomycin, up to 1 gm
  • J3010 — Injection, fentanyl citrate, 0.1 mg
  • J3030 — Injection, sumatriptan succinate, 6 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
  • J3031 — Injection, fremanezumab-vfrm, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self-administered)
  • J3032 — Injection, eptinezumab-jjmr, 1 mg
  • J3060 — Injection, taliglucerase alfa, 10 units
  • J3070 — Injection, pentazocine, 30 mg
  • J3090 — Injection, tedizolid phosphate, 1 mg
  • J3095 — Injection, telavancin, 10 mg